| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $336.6M | +29.7% | +68.3% |
| Cost of Revenue | $670.2M | +26.0% | +62.5% |
| R&D Expense | $325.3M | +18.8% | +0.3% |
| SG&A Expense | $283.1M | +10.2% | +21.2% |
| Operating Income | -$942.0M | -17.3% | -22.3% |
| Pre-tax Income | -$978.8M | -80.7% | +1.3% |
| Income Tax | -$363K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.64B | -8.9% | -13.7% |
| Short-term Investments | $701.9M | -31.9% | -55.5% |
| Accounts Receivable | $137.6M | +9.9% | +40.1% |
| Inventory | $981.1M | +37.5% | +93.6% |
| Current Assets | $3.80B | -3.8% | -10.5% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.02B | — | — |
| Capital Expenditures | $542.7M | — | — |
| Investing Cash Flow | $1.56B | — | — |
| Financing Cash Flow | $517.7M | — | — |
| Free Cash Flow | -$2.56B | — | — |
| +84.7% |
| -174.5% |
| Net Income | -$978.4M | -81.4% | +1.4% |
| EPS (Basic) | -$3.31 | -1279.2% | -707.3% |
| EPS (Diluted) | -$3.31 | -1082.1% | -707.3% |
| $8.82B |
| -0.5% |
| +3.9% |
| Current Liabilities | $2.10B | +37.2% | +83.7% |
| Long-term Debt | $2.04B | +0.1% | +2.0% |
| Total Liabilities | $5.10B | +11.0% | +7.5% |
| Stockholders' Equity | $1.80B | -25.2% | -32.9% |